IQVIA Holdings Inc.
IQV
Rang in Aktien
#556
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Aktienkurs
$269.04
Marktkapitalisierung
$44.28B
Veränderung (1 Tag)
1.20%
Veränderung (1 Jahr)
26.88%
Land
US
Handel IQVIA Holdings Inc. (IQV)
Kategorie
Healthcare
Gewinn für IQVIA Holdings Inc. (IQV)
Gewinn im Jun 2026 TTM: $1.61B
Laut den aktuellen Finanzberichten von IQVIA Holdings Inc. betragen die aktuellen Gewinne des Unternehmens $1.61B. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $1.67B, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $1.46B betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von IQVIA Holdings Inc. von 2010 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $1.61B | -0.25% |
| 2025 | $1.61B | -3.36% |
| 2024 | $1.67B | 14.39% |
| 2023 | $1.46B | 7.99% |
| 2022 | $1.35B | 19.14% |
| 2021 | $1.13B | 198.42% |
| 2020 | $380.00M | 10.79% |
| 2019 | $343.00M | 0.00% |
| 2018 | $343.00M | 12.83% |
| 2017 | $304.00M | -26.21% |
| 2016 | $412.00M | -24.68% |
| 2015 | $547.00M | 8.10% |
| 2014 | $506.00M | 56.60% |
| 2013 | $323.12M | 19.67% |
| 2012 | $270.00M | 5.70% |
| 2011 | $255.43M | 5.67% |
| 2010 | $241.73M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $7.61B | 372.90% |
US
|
|
| $4.76B | 195.96% |
US
|
|
| $-252.70M | -115.71% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 3.05% |
US
|
